Background: CO 2 retention and skeletal muscle atrophy occur in patients with lung diseases and are associated with poor clinical outcomes. Results: Hypercapnia leads to AMPK/FoxO3a/MuRF1-dependent muscle fiber size reduction. Conclusion: Hypercapnia activates a signaling pathway leading to skeletal muscle atrophy. Significance: High CO 2 levels directly activate a proteolytic program of skeletal muscle atrophy which is of relevance to patients with lung diseases.
residue (Thr-172) within the kinase domain of the ␣-catalytic subunit is required for AMPK activation (23) . Recently AMPK has been implicated in the control of muscle mass by increasing protein degradation through the ubiquitin proteasome system (UPS) and autophagy (24) . AMPK activation was reported to regulate myofibrillar protein degradation through the transcription factor FoxO (25) . Here we describe that hypercapnia, by activating AMPK, leads to phosphorylation and nuclear translocation of FoxO3a and MuRF1 up-regulation, which results in skeletal muscle atrophy.
EXPERIMENTAL PROCEDURES
Reagents-All cell culture reagents were from Corning Life Sciences (Tewksbury, MA). HRP-conjugated goat anti-mouse secondary antibody was from Bio-Rad, and GAPDH and HRPconjugated goat anti-rabbit antibody were from Cell Signaling Technology (Danvers, MA). All other chemicals were purchased from EMD Millipore (Billerica, MA) or Sigma. Reagents for production of cDNA and quantitative real time PCR (qPCR) were from Bio-Rad and Life Technologies. The DNA and mRNA isolation kits were from Qiagen (Germantown, MD). Primers were purchased from Integrated DNA Technologies (Coralville, IA). Restriction endonucleases were obtained from Promega (Madison, WI).
Animals-Adult (14 -16 weeks old) male C57Bl/6 mice were obtained from The Jackson Laboratory (Bar Harbor, ME), and age-matched male MuRF1 Ϫ/Ϫ mice and wild-type littermates (MuRF1 ϩ/ϩ ) on a 129S/C57Bl/6 background have been described elsewhere (20, 26) . For arterial blood gas measurements, C57BL/6 mice with a common carotid artery catheter were purchased from Charles Rivers Laboratories (Wilmington, MA). All animals were provided with food and water ad libitum, maintained on a 14-h light/10-h dark cycle, and handled according to National Institutes of Health guidelines. All of the procedures involving animals were approved by the Northwestern University Institutional Animal Care and Use Committee. For high CO 2 exposure, animals were maintained in a hypercapnia chamber (BioSpherix Ltd., Lacona, NY) for 3, 7, 14, or 21 days. The chamber's atmosphere was continuously monitored and adjusted with ProOx/ProCO 2 controllers (BioSpherix Ltd) in order to maintain 10% CO 2 and 21% O 2 , with a temperature of 20 -26°C and a relative humidity between 40 and 50%. These settings resulted in an arterial partial pressure of carbon dioxide (paCO 2 ) of ϳ75 mm Hg and arterial partial pressure of oxygen (paO 2 ) of ϳ100 mm Hg, whereas in animals maintained in room air paCO 2 was ϳ40 mm Hg and paO 2 was ϳ100 mm Hg (7, 27) . None of the animals developed appreciable distress. At selected time points animals were anesthetized with Euthasol (pentobarbital sodium/phenytoin sodium), soleus, gastrocnemius, and tibialis anterior muscles were excised, blotted dry, and weighed. Muscles were then either frozen in liquid nitrogen-cooled isopentane for cryosectioning or snap-frozen in liquid nitrogen for protein, RNA, or DNA extraction.
Arterial Blood Gases-Arterial blood gases were obtained from unanesthetized, restrained mice with surgically implanted carotid artery catheters. Mice were allowed to adapt for 1 to 2 days after shipping before being placed in the hypercapnia chamber and before any arterial blood gases were drawn. Arte-rial blood was analyzed for pH, PaCO 2 , PaO 2 , and HCO 3 Ϫ using a pHOx Plus Blood Gas Analyzer (Nova Biomedical, Waltham, MA) that was calibrated daily.
Immunohistochemistry and Fiber Size and Type Assessment-Soleus, gastrocnemius, and tibialis anterior serial transverse cryosections (8 m) were obtained from the Northwestern University Mouse Histology and Phenotyping Laboratory and mounted on glass slides. Sections were fixed in 4% formaldehyde, permeabilized, and blocked. Immunostaining was performed with laminin primary antibody (1:50 dilution; Sigma) followed by Alexa Fluor 568-conjugated secondary antibody (1:200 dilution; Life Technologies). Type I fibers were stained with anti-type I myosin heavy chain (A4.840, 1:50 dilution, DSHB, Iowa City, IA), and type II fibers were stained with antimyosin (Skeletal, Fast)-alkaline phosphatase (Sigma). Images were acquired with a Zeiss LSM 510 confocal microscope using a 40ϫ objective (Northwestern University Center for Advanced Microscopy) and analyzed using Zeiss LSM5 Image Browser software. Fiber size was studied by measuring the fibers' minimal inner diameter (at least 100 fibers per muscle), defined as the minimum diameter from inner border to inner border, passing through the center of the muscle fiber. This parameter has been shown to be very insensitive to deviations from the "optimal" cross-sectioning profile, as compared with direct measure of fiber cross-sectional area (28) . Cross-sectional area (CSA) was calculated using this diameter, and results were expressed as mean CSA Ϯ S.E. and as percentage of fibers distributed by size.
Grip Strength Test-Forelimb skeletal muscle strength was assessed using a digital grip strength meter (Columbus Instruments, Columbus, OH) as described (29) . Grip strength was measured in each animal six successive times, and the average of the highest four values for each mouse was used.
Cell Culture, Adenoviral Infection, and Myotube Analysis-C2C12 mouse myoblasts (ATCC, CRL1772) were cultured and differentiated as described elsewhere (30) . In brief, cells were allowed to grow in p60 plates until they reached ϳ90 -95% confluence, and then culture media was changed to prewarmed 2% horse serum DMEM (differentiation media). The differentiation media was renewed every 18 -24 h, and cells were allowed to differentiate for 4 -6 days. The FoxO3 mutant bearing six serine-to-alanine mutations on AMPK phosphorylation sites was generously provided by Dr. Anne Brunet (Department of Genetics, Stanford University, CA) (31) . The sequence was confirmed by traditional sequencing at the Northwestern University Genomics Core Facility, and the construct was incorporated into an adenoviral vector (Ad-FoxO3a-6A, Vector BioLabs, Malvern, PA). Commercially available wild-type FoxO3-containing adenovirus vector (Ad-FoxO3a-WT, Vector BioLabs) was used as a control. For infection, myotubes were incubated with the corresponding adenovirus at six plaqueforming units per cell for 24 h. Images were acquired using a Nikon Eclipse TE2000-U inverted scope with a 40ϫ objective. Myotube diameters were quantified by measuring ϳ160 tube diameters (5-10 measurements per fiber) from five random fields using MetaMorph Software (Molecular Devices, Sunnyvale, CA). CO 2 Medium and CO 2 Exposure-For the different experimental conditions, initial solutions were prepared with DMEM/F-12/Tris base/MOPS (3:1:0.25:0.25) containing 2% horse serum, 100 units/ml penicillin, and 100 g/ml streptomycin. The buffering capacity of the medium was modified by changing its initial pH with Tris base and MOPS to obtain a pH of 7.4 at the various CO 2 levels (pCO 2 40, 60, and 120 mm Hg). The desired CO 2 and pH levels were achieved by equilibrating the medium overnight in a humidified chamber (C-Chamber, BioSpherix Ltd.). The atmosphere of the C-Chamber was controlled with a ProCO 2 carbon dioxide controller (BioSpherix Ltd.). In this chamber cells were exposed to the desired pCO 2 while maintaining 21% O 2 balanced with N 2 . Before and after CO 2 exposure, pH, pCO 2 , and pO 2 levels in the medium were measured using a Stat Profile pHOx blood gas analyzer (Nova Biomedical Corp.). Experiments were started by replacing the culture medium with the CO 2 -equilibrated medium and incubating in the C-Chamber for the desired time.
Transfection of C2C12 Cells with siRNA-After 3 days of differentiation, media were removed from C2C12 cells and replaced with antibiotic-free differentiation media, and transfection was performed after 12 h. Before transfection, C2C12 myotubes were washed twice with DMEM and transfected with mouse AMPK␣1 and -2, FoxO3a, and MuRF1 siRNA duplexes (100 pmol) from Santa Cruz Biotechnology (Santa Cruz, CA) by using Lipofectamine RNAiMAX (Life Technologies) according to the manufacturer's recommended protocol. Cells were incubated with the RNA-Lipofectamine complexes for 4 -6 h at 37°C. After this period, the transfection complex was supplemented with differentiation media up to 3 ml, and experiments were performed 48 h later. A scrambled siRNA was used as a control (Life Technologies). FIGURE 1. Hypercapnia causes muscle atrophy in mice without changes in metabolic phenotype. C57Bl/6 mice were exposed to 10% CO 2 (HC) for 7, 14, and 21 days or maintained in room air (CT), and soleus muscles were excised, frozen, and cryosectioned (8 m thickness). A, soleus muscle wet weight (n Ն 7). B, the upper panel shows soleus muscle cross-sections immunostained with laminin antibody. Scale bars, 50 m. n Ն 4. The lower panel shows a histograms of fiber size distribution. C, fiber CSA from soleus muscle of mice exposed to room air or 10% CO 2 for 14 and 21 days. D, muscle force assessed via the grip strength test (n Ն 10). Results are represented normalizing the average grip of each mouse by the body weight at the corresponding day. E, percentage of type I and type II fibers in soleus muscle of mice exposed to room air or 10% CO 2 for 14, and 21 days (n Ն 6). F, fiber CSA from type I and type II fibers from soleus muscle of mice exposed to room air or 10% CO 2 for 14 and 21 days ( n Ն6). *,p Ͻ 0.05; **, p Ͻ 0.01.
TABLE 1 Exposure to high CO 2 causes normoxic hypercapnia
C57Bl/6 mice were exposed to control conditions at room air (CT, n ϭ 7) or high CO 2 /hypercapnia for different time points (HC-3 days, n ϭ 6; HC-5 days, n ϭ 3; HC-7 days, n ϭ 3). Samples were analyzed with a pHOx Plus Blood Gas Analyzer, as described under "Experimental Procedures." Western Blot Analysis-C2C12 myotubes were homogenized in Lysis Buffer (Cell Signaling Technology). Muscle samples were homogenized on ice with cold lysis buffer in a 10-fold (wt/wt) excess of lysis buffer, pH 7.6, that contained 8.7 mM NaH 2 PO 4 , 58 mM Na 2 HPO 4 , 144 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, and 1ϫ protease inhibitor mixture (Roche Applied Science) as previously described (32) using a Polytron PT 10-35 homogenizer (Thermo Scientific, Waltham, MA). Samples were centrifuged at 22,000 ϫ g for 10 min at 4°C, and after 2 spins the final supernatant was collected. Protein concentrations were determined by the BCA assay (Thermo Scientific Pierce Protein Biology Products, Rockford, IL). Proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), transferred to nitrocellulose membranes, immunoblotted, and visualized by chemiluminescence following the manufacturer's instructions (Perkin Elmer Life Sciences). The following commercially available antibodies and dilutions were used for Western blotting: rabbit anti-pAMPK␣ (Thr-172), anti-AMPK␣, anti-pACC (Ser-79), anti-ACC, anti-GAPDH, and anti-FoxO3a were from Cell Signaling Technology and used at 1:1000; rabbit anti-actin (1:2000) was from Sigma; rabbit anti-MuRF1 (1:1000) was from ECM Biosciences (Versailles, KY); rabbit anti AMPK␣1 (1:1000) was from EMD Millipore; rabbit AMPK␣2 (1:1000) was from Novus Biologicals (Littleton, CO); rabbit anti-Pol II (1:200) was from Santa Cruz Biotechnology. Rabbit anti-pFoxO3 (Ser-588) was generously gifted by Dr. Anne Brunet and used at a dilution of 1:500. Primary antibodies were detected with horseradish peroxidase-conjugated secondary antibodies. Quantification of protein levels was performed by densitometric scanning with ImageJ 1.29X (National Institutes of Health).
Variable
Immunoprecipitation-C2C12 cells were differentiated for 4 days and then transfected with Ad-Foxo3a-6A mutant or with wild-type FoxO3a-containing adenovirus. Cell lysates were prepared, and aliquots containing 1000 g of protein were rotated overnight at 4°C with FoxO3a antibody (1:200) or control IgG in the presence of 40 l protein A/G-agarose beads (Santa Cruz Biotechnology). Samples were then centrifuged, and the beads were resuspended in SDS-loading buffer and separated in a 10% polyacrylamide gel.
RNA Extraction, cDNA Synthesis, and Quantitative RT-PCR-Quantification of ribosomal DNA transcription was done as previously described (33) . Muscle RNA was extracted using TRIzol reagent (Life Technologies). Total RNA was determined spectrophotometrically using a Nanodrop ND-1000 (Saveen & Werner, Limhamnsvägen, Sweden) at 260 nm and quality-assessed visually using agarose gel electrophoresis. cDNA was synthesized using Superscript VILO cDNA synthesis kit (Life Technologies). Quantitative RT-PCR was performed using GoTaq qPCR Master Mix (Promega) on a CFX384 Real-time PCR detection system (Bio-Rad). The primers used were 5Ј-CCA AGT GTT CAT GCC ACG TG-3Ј (forward) and 5Ј-CGA GCG ACT GCC ACA AAA A-3Ј (reverse). Each sample was run in triplicate, and relative expression levels of transcripts of interest were calculated using the comparative Ct (⌬⌬Ct) method with glyceraldehyde-3-phosphate dehydrogenase as housekeeping gene. Data were analyzed using the Bio-Rad CFX manager software (Version 2.0).
Centralized Nuclei Analysis-8-m frozen soleus muscle sections were stained with hematoxylin and eosin (H&E), and histological images were acquired at 40ϫ magnification using the Zeiss Axioskop upright brightfield microscope with a CRi NUANCE spectral camera. Low magnification (10ϫ) images that captured the entire soleus muscle in cross-section were used to count the centralized/internal nuclei. The total number of fibers counted in each cross-section was between 600 and 700. The total number of myofibers counted was similar between all the mice analyzed.
Evaluation of FoxO3 Nuclear Translocation-C2C12 myotubes were harvested and then nuclear/cytosol fractionation was performed with a commercially available kit (BioVision, Milpitas, CA) according to the manufacturer's instructions.
The nuclear fraction was then sampled, and proteins were separated by SDS-PAGE, transferred to nitrocellulose membranes, and immunoblotted with anti-FoxO3a antibody. To assess the phosphorylation of FoxO3a in the nuclear fraction, we transfected C2C12 with Ad-FoxO3a-WT, and after 24 h cells were exposed to high CO 2 for 4 h, and the nuclear fractions were isolated. FoxO3a was immunoprecipitated from the nuclear fraction, and phosphorylation was assessed by Western blot with the phospho-Ser-588 antibody.
Protein/DNA Ratio Determination-C2C12 myotubes were exposed to high CO 2 levels for 24 h, and then samples were homogenized by sonication (Branson Sonifer 250). The total amount of protein was measured with a Bradford assay, and total DNA was measured with the fluorochrome Hoechst 33258, both from Bio-Rad, in a Fluoroskan Ascent FL Microplate Fluorometer (Thermo Scientific).
Statistics-Data are expressed as the mean Ϯ S.E. When comparisons were performed between two groups, significance was evaluated by Student's t test, and when more than two groups were compared, analysis of variance was used followed by the Dunnett test using GraphPad Prism software. Results were considered significant when p Ͻ 0.05.
RESULTS
Hypercapnia Causes Skeletal Muscle Atrophy in Mice-To investigate whether high CO 2 causes muscle atrophy, mice were exposed to 10% CO 2 and 21% O 2 (hypercapnia) or to room air (normocapnia), and skeletal muscle wet weight, fibers CSA, and grip strength were assessed, and arterial blood gases were FIGURE 4. High CO 2 exposure causes reduction in myotube diameter associated with a decrease in total protein content and down-regulation of anabolic genes. A, representative images of C2C12 myotubes exposed to 40, 60, and 120 mm Hg CO 2 , and the graph depicts average myotubes diameter (n ϭ 3). Scale bars, 30 m. B, representative images of C2C12 myotubes exposed to 0 (CT), 6, 24, and 48 h CO 2 (n ϭ 3). C, protein/DNA ratio of C2C12 myotubes (Table 1) . Also, mice breathing high CO 2 had decreased soleus muscle wet weight as compared with room air-breathing mice (Fig. 1A) . Fig. 1B, upper panel, shows images of laminin-stained soleus cryosections in which quantitative analysis indicated a decrease in CSA during hypercapnia (Fig.  1C ). In agreement with these findings, Fig. 1B, lower panel, shows a leftward shift in the size distribution histogram indicating a predominance of thinner fibers in muscles from hypercapnic mice. Muscle strength was also decreased in mice exposed to high CO 2 , as assessed by the grip strength method (Fig. 1D ). Soleus muscles are composed by muscle fiber type I and II. We did not observe a change in the soleus' fiber composition or a predominant fiber's type atrophy with both type of fibers decreasing their CSA by ϳ20 -25%, which is consistent with the data in Fig. 1C (Fig. 1, E and F) . The atrophic effect induced by hypercapnia on the soleus muscle was also observed in the gastrocnemius and tibialis anterior (Fig. 2, A and B ) from mice exposed to CO 2 for 14 and 21 days, suggesting that the decrease in fiber size caused by hypercapnia is a generalized effect. Also, soleus muscle from hypercapnic mice displayed a time-dependent increase in myonuclear centralization respective to the total number of fibers ( Fig. 3) , likely representing tissue response to injury (34) . Moreover, the data show that at 21 days there was a significant increase in the percentage of fibers with centralized nuclei (1.007Ϯ.227 versus 3.007Ϯ.009 p Յ 0.01 n ϭ 3).
High CO 2 Leads to Decreased Myotube Diameter, Protein Abundance, and Down-regulation of Anabolic Genes-C2C12 myotubes exposed to increasing levels of CO 2 became progressively thinner (Fig. 4A) , with significant differences observed after 24 h of exposure (Fig. 4B) . Therefore, all the subsequent in vitro experiments were performed at 24 h and 120 mm Hg (designated as "hypercapnia") as we observed the highest effect at this level. To further explore the effect of hypercapnia on myotube diameter, we measured total protein content (protein/ DNA ratio) and observed that myotubes exposed to hypercapnia had lower protein content at 24 h (Fig. 4C ). We also found a time-dependent decrease in the expression of the 45 S pre-rRNA transcripts, a marker of de novo RNA synthesis (Fig. 4D) .
MuRF1 Mediates the High CO 2 -induced Myotube Atrophy-To determine whether the ubiquitin proteasome system was involved in high CO 2 -induced skeletal muscle atrophy, we treated myotubes with the proteasome inhibitor MG-132 (10 M for 12 h) or the ubiquitin-conjugating enzyme inhibitor (UBE1; 10 M for 12 h) and exposed them to hypercapnia. Dexamethasone (10 M) was used as a positive control of UPSmediated muscle atrophy (21) . As shown in Fig. 5 , MG-132 and UBE1 prevented the hypercapnia-induced reduction in myotube diameter, and the effect of dexamethasone (a positive control) was prevented with MG-132. We assessed MuRF1 expression in myotubes and soleus muscle from mice exposed to hypercapnia and found significant increases in MuRF1 expression in myotubes ( Fig. 6A ) and in soleus muscle (Fig. 6B ). To determine whether MuRF1 is required for hypercapnia-induced myotube atrophy, we transfected differentiated myotubes with MuRF1 small interfering RNA (siRNA) and found that silencing MuRF1 had a protective effect against hypercapnia-induced myotube atrophy (Fig. 6C ). To validate these find-ings and assess the role of MuRF1 in vivo, we exposed MuRF1 Ϫ/Ϫ mice to high CO 2 for 21 days and found that the absence of MuRF1 prevented the reduction in muscle strength (Fig. 7A) , a decrease in soleus mean fiber CSA (Fig. 7B) , and the leftward shift in fiber size distribution observed in MuRF1 ϩ/ϩ mice (Fig. 7C) .
Hypercapnia Causes Muscle Atrophy via AMPK-dependent Pathway-Exposure of myotubes to hypercapnia led to an increase in both AMPK and its target acetyl-CoA carboxylase (ACC) phosphorylation, which occurred as early as 15 min and lasted for at least 24 h (Fig. 8A ). AMPK has recently been shown to mediate skeletal muscle protein degradation via atrogin-1 and MuRF1 (25, 35) . To determine whether AMPK is a necessary mediator of high CO 2 -induced muscle atrophy, myotubes were transfected with scrambled or specific AMPK␣1 or -2 siRNA. We found that AMPK␣2, but not AMPK␣1, was necessary for CO 2 -induced decrease in myotube diameter (Fig. 8B) . Furthermore, we also found that high CO 2 -driven up-regulation of MuRF1 is mediated by AMPK␣2, as MuRF1 induction was abrogated in high CO 2 -exposed cells transfected with AMPK␣2 siRNA (Fig. 8C) . Representative graph and images of C2C12 myotubes treated with vehicle, MG-132, and E1-inhibitor UBE1 exposed to 40 mmHg (CT) or 120 mmHg (HC) CO 2 for 24 h or pretreatment with MG-132 or vehicle (V) and exposed to dexamethasone for 12 h (Dexa, 10 M) (n ϭ 3). Scale bars, 30 m. ***, p Ͻ 0.001. FIGURE 6. MuRF1 regulates high CO 2 -induced reduction in myotube diameter. A and B, representative immunoblots of C2C12 myotubes (A) and soleus muscle lysates (B) exposed to CO 2 for increasing times and probed with an antibody specific for MuRF1 (n ϭ 3). C, representative graph and images of C2C12 myotubes transfected with scrambled (Scr) or specific MuRF1 siRNA and exposed to 40 mmHg (CT) or 120 mmHg (HC) CO 2 for 24 h (n ϭ 3). Scale bars, 30 m. The graph represents the average myotubes diameter. Representative immunoblots of MuRF1 (transfection control), actin, and GAPDH (loading controls). *, p Ͻ 0.05; **, p Ͻ 0.01; ***, p Ͻ 0.001. FIGURE 7. MuRF1 ؊/؊ mice are protected against high CO 2 -induced muscle atrophy. MuRF1 Ϫ/Ϫ mice and wild-type littermates (MuRF1 ϩ/ϩ ) were exposed to 10% CO 2 (HC) for 21 days or maintained in room air (CT), and soleus muscles were excised, frozen, and cryosectioned (8-m thickness). A, measured grip strength from MuRF1 Ϫ/Ϫ mice and wild-type littermates. n Ն 6. Results are represented normalizing the average grip of each mouse by the body weight (BW) at the corresponding day. B, soleus muscles from MuRF1 Ϫ/Ϫ mice and wild-type littermates were immunostained with laminin antibody and fiber CSA was analyzed. n Ն 3). Scale bars, 50 m. C, fiber size distribution histograms from MuRF1 Ϫ/Ϫ mice and wild-type littermates (n Ն 6). *, p Ͻ 0.05. Fig. 9A , hypercapnia led to FoxO3a nuclear translocation, which was prevented by silencing AMPK␣2 but not AMPK␣1 (Fig. 9B) . Moreover, transfection of myotubes with scrambled or specific FoxO3a siRNA revealed that silencing FoxO3a prevented the high CO 2 -induced up-regulation of MuRF1 and the decrease in myotube diameter (Fig. 9, C and D) .
Hypercapnia Causes AMPK␣2-dependent FoxO3a Nuclear Translocation, Which Is Needed for MuRF1 Up-regulation and Reduction in Myotube Diameter-As shown in
AMPK Phosphorylates FoxO3a, Which Regulates MuRF1 during Hypercapnia-induced Reduction in Myotube Diameter-It has been reported that AMPK regulates FoxO3a phosphorylation (31, 36) and that it directly phosphorylates FoxO3a and that mutation of Thr-179, Ser-399, Ser-413, Ser-555, Ser-588, and Ser-626 to alanine (FoxO3a-6A) results in a reduction of AMPK-dependent phosphorylation of FoxO3a (31) . To assess whether hypercapnia leads to AMPK-dependent phosphorylation of FoxO3a, myotubes were transfected with an adenovirus coding for FoxO3a wild type (Ad-FoxO3a-WT) or mutated at the six AMPK phosphorylation sites. After FoxO3a immunoprecipitation, Western blots probed with an antibody that specifically recognizes Ser(P)-588 but does not recognize the non-phosphorylated form (31) showed that high CO 2 levels increased Ser-588 phosphorylation only in FoxO3a-WT (Fig.  10A) . Moreover, the phosphorylated form of FoxO3a is present in the nuclei (Fig. 10B ). Overexpression of Ad-FoxO3a-6A prevented the high CO 2 -induced up-regulation of MuRF1 (Fig.  10C ) and the decrease in myotube diameter (Fig. 10D) , indicating that hypercapnia leads to AMPK-dependent phosphorylation of FoxO3a, which is necessary to up-regulate MuRF1 expression and decrease myotube diameter.
DISCUSSION
Muscle atrophy is being increasingly recognized as a major contributor to worse clinical outcomes in patients with pulmonary diseases (4, 37, 38) , and indeed recovery of lower limbs muscle mass of COPD patients in the setting of pulmonary rehabilitation has proven to be beneficial (39) . Muscle atrophy is characterized by a decrease in muscle fiber diameter, protein content, and force production (24) . We report here that hypercapnia, which occurs in patients with chronic respiratory diseases, causes skeletal muscle atrophy. It has been reported that tobacco smoke, which is rich in CO 2 and causes COPD, is also associated to muscle dysfunction even in early stages of lung A, AMPK and acetyl-CoA carboxylase (ACC) phosphorylation in myotubes exposed to 40 mmHg (CT) or 120 mmHg (HC) hypercapnia for different time points, as shown by immunoblots of samples probed with specific antibodies (n ϭ 3). B, representative graph and images of myotubes diameters transfected with scrambled (Scr), AMPK␣1 or 2 siRNA and exposed to high CO 2 . Scale bars, 30 m. C, myotubes were transfected with Scr, AMPK␣1 or -␣2 siRNA and exposed to high CO 2 . Representative immunoblots of cell lysates are shown with specific antibodies. Samples were probed with MuRF1 specific antibody to detect its level of induction under the different conditions (n ϭ 3). Actin was used as a loading control. *, p Ͻ 0.05; ***, p Ͻ 0.001. FIGURE 9. Hypercapnia causes AMPK␣2-dependent FoxO3a nuclear translocation, which is necessary for MuRF1 up-regulation and reduction in myotube diameter. A, representative immunoblots from myotubes exposed to 40 mmHg (CT) and 120 mmHg (HC) CO 2 ; nuclear fractions were obtained, and samples were incubated with FoxO3a specific antibody (n ϭ 5). B, representative immunoblots from myotubes exposed to high CO 2 ; myotubes were transfected with scrambled (Scr), AMPK␣1 or -2 siRNA, nuclear and cytosolic fractions were obtained, and samples were incubated with FoxO3a-specific antibody (n ϭ 3). C, representative immunoblots from myotubes exposed to high CO 2 for 24 h; myotubes were transfected with Scr or FoxO3a siRNA and probed with MuRF1 specific antibodies (n ϭ 3). D, representative graph and images of C2C12 cells transfected with Scr or FoxO3a siRNA and exposed to high CO 2 for 24 h (n ϭ 3). Polymerase II and actin were used as loading controls. Scale bars, 30 m. *, p Ͻ 0.05. FIGURE 10. Both high CO 2 -induced up-regulation of MuRF1 and myotube atrophy require FoxO3a phosphorylation by AMPK. A, representative blots from immunoprecipitation of FoxO3a obtained from myotubes previously infected with Ad-WT-FoxO3a and Ad-FoxO3a-6A and then exposed to 40 mmHg (CT) and 120 mmHg (HC) CO 2 . Blots were analyzed using Ser(P)-588 antibody (n ϭ 3). B, representative blots from immunoprecipitation of FoxO3a from nuclear fractions of myotubes previously infected with Ad-WT-FoxO3a and exposed to high CO 2 for 4 h. Blots were analyzed with 588 antibody and FoxO3a and polymerase II (pol II) as a loading control. n ϭ 3. C, representative immunoblots from myotubes exposed to high CO 2 for 24 h; myotubes were previously transfected with Ad-WT-FoxO3a-6A and Ad-FoxO3a-6A and probed with MuRF1 specific antibodies. Total FoxO3a was used as a loading control (n ϭ 4). D, representative graph and images transfected with Ad-WT-FoxO3a-6A and Ad-FoxO3a-6A and exposed to high CO 2 for 24 h (n ϭ 3). Scale bars, 30 m. *, p Ͻ 0.05; **, p Ͻ 0.01; ***, p Ͻ 0.001. disease (40) . We observed that animals exposed to high CO 2 had high PaCO 2 and also, with time, higher bicarbonate values (Table 1) , reflecting renal compensation of the respiratory acidosis. We found that exposing mice to high CO 2 levels similar to those observed in hypercapnic patients with COPD (41) leads to muscle atrophy as evidenced by a progressive decrease in muscle mass, fibers cross-sectional area, and limb grip strength. Hypercapnia did not cause selective fiber type atrophy in the soleus muscle or a switch from slow-twitch to fast-twitch fibers, however, the antibody used in the study does not distinguish among the different type II fibers; thus, a switch from type IIa to IIb cannot be excluded (see Fig. 1, E and F) . We show that high CO 2 results in more centralized nuclei in the soleus muscle ( Fig. 3) , which represents a tissue response to myofiber injury (34) . Although skeletal muscle atrophy has not classically been associated to cellular damage and repair but to an imbalance of protein turnover, a recent study shows that cancer-associated muscle atrophy is characterized by cellular injury and repair with activation and proliferation of satellite cells (42) . Therefore, our finding of nuclear centralization could similarly suggests myofiber response to high CO 2 -mediated injury. Cultured myotubes exposed to high CO 2 levels undergo a dose-and time-dependent atrophy that was prevented by MG-132 and UBE1, suggesting a role for the UPS in this process. The UPS has been described to regulate skeletal muscle atrophy in patients with chronic lung diseases (43) (44) (45) (46) . In addition, there have been reports of skeletal muscle atrophy via the UPS during acute lung injury and in patients with pulmonary vascular disease (47) (48) (49) . Our data suggest a direct link between hypercapnia and muscle atrophy via the UPS in this process. Moreover, we found that hypercapnia in vivo and in vitro increases the expression of MuRF1 (Fig. 6, A and 6) , whereas we did not find an increase in atrogin-1 (data not shown).
AMPK has been reported to play a role in skeletal muscle atrophy (23) . We observed that the hypercapnia-dependent activation of AMPK in cultured myotubes occurs very early during high CO 2 exposure and persists for at least 24 h. Previous evidence suggest that AMPK mediates muscle catabolism through increased expression of FoxO transcription factors (50) , and AICAR-induced AMPK activation of atrogin-1 and MuRF1 (25) . Also, up-regulation of AMPK along with an increase ubiquitin-protein conjugates and MuRF1 gene transcription has been reported in skeletal muscles of patients with COPD (51) . We found that hypercapnia-driven muscle atrophy is mediated by AMPK␣2, which is the major catalytic subunit isoform in muscle (23) . Previous evidence from lung alveolar epithelialcellssuggeststhatCO 2 -mediatedAMPK␣1phosphorylation occurs through Ca 2ϩ /calmodulin-dependent kinase kinase ␤ (CaMKK-␤) (27) , making this pathway a possible activator of AMPK in the present model. Alternatively, given that CO 2 exposure was found to cause mitochondrial dysfunction, decreased O 2 consumption, and ATP production in fibroblasts and alveolar epithelial cells (52) , AMPK activation could also occur via LKB1. Interestingly, it has been reported that AMPK␣2 activity is more dependent on high AMP levels than the ␣1 isoform (53), making CO 2 -driven mitochondrial dysfunction an interesting potential upstream activator of AMPK, which should be further addressed in future works. Other mechanisms such as inhibition of protein phosphatases or activation of a different upstream kinase could also be relevant in the present model (54) .
We also found that hypercapnia decreased the expression of 45 S pre-rRNA, which is the precursor of the ribosomal RNA components 28 S, 18 S, and 5.8 S. Increased transcription of the 45 S pre-rRNA is one of the earliest events in muscle hypertrophy (33, 55) , and its expression is rapidly down-regulated in atrophying skeletal muscle, indicating a reduction in the anabolic capacity of the muscle during catabolic stress (56) . AMPK is known to down-regulate rRNA synthesis by phosphorylating the RNA polymerase I-associated transcription factor TIF-IA (57), preventing the assembly of functional transcription initiation complexes. Thus, it appears that in addition to regulating the expression of MuRF1 and muscle catabolism, hypercapnia exposure also leads to the attenuation of the anabolic capacity of muscle cells.
A recent study showed that acute lung injury associated muscle atrophy requires the activation of the NF-B for MuRF1 to be induced, whereas our findings suggest that high CO 2 triggers muscle catabolism through FoxO3a and MuRF1 regulation (49) . FoxO regulation in response to external stimuli is mostly determined by changes in its phosphorylation state and subcellular localization, which modulates its access to nuclear DNA (58) . Different kinases, including Akt, mitogen-activated protein kinases, and AMPK, have been shown to regulate FoxO activation (59) , and Greer et al. (31) have described that AMPK directly phosphorylates FoxO3a and that AMPK is necessary and sufficient for the phosphorylation of FoxO3a. We found that high CO 2 levels cause AMPK-dependent phosphorylation of FoxO3a and that when FoxO3a-6A mutant is overexpressed, the phosphorylation of the AMPK-targeted site Ser-588 is prevented. Hypercapnia leads to AMPK␣2-dependent nuclear translocation of FoxO3a, which regulates MuRF1 expression leading to muscle atrophy. Although AMPK has been shown to modulate FoxO3a expression through a PGC-1␣-dependent mechanism (60), we did not find changes in total cellular FoxO3a abundance during high CO 2 exposure (see Fig. 9 , C and D). AMPK phosphorylates FOXO3a at amino acids that are different from the sites described for other kinases (Akt, SGK (serum-and glucocorticoid-inducible kinase), CK1, DYRK1, JNK, IKK-, and MST1) (31) . Interestingly, like AMPK, Akt also controls protein synthesis and protein degradation (16) . FoxO3a is one of the intersection points between both pathways as activation of Akt phosphorylates FoxOs, which excludes them from the nuclei, preventing their functions as transcription factors (16, 58) .
In summary, we report that hypercapnia triggers skeletal muscle atrophy though a pathway that involves the activation of AMPK␣2, phosphorylation of FoxO3a, and induction of MuRF1 (Fig. 11 ). This pathway is of pathophysiological relevance to patients with hypercapnic respiratory diseases.
